Atlas Trials

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Clinical trial NCT06502171 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06502171
Sponsor
Girish Dhall, MD
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Neurofibromatosis 1Plexiform Neurofibroma
Start date
2026-08-01
Primary completion
2033-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.